The ACTA2 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population of HEK293T cells with targeted disruption of the ACTA2 gene, eliminating smooth muscle alpha-actin production. This loss-of-function model provides a heterogeneous yet stable knockout background for studying ACTA2-dependent mechanisms in a well-characterized human embryonic kidney epithelial host. By avoiding clonal bias, the polyclonal pool ensures robust functional studies, suitable for dissecting cytoskeletal and contractile processes.
The parental HEK293T cell line is a widely used derivative of HEK293 that stably expresses a temperature-sensitive mutant of SV40 large T antigen, promoting episomal replication of plasmids with the SV40 origin. These human embryonic kidney epithelial cells are adapted to high-density suspension culture, making them ideal for scalable recombinant protein production, transient transfection, and lentiviral packaging. Their genetic tractability and fast growth facilitate straightforward gene editing, establishing HEK293T as a premier host for generating knockout models.
ACTA2 encodes smooth muscle alpha-actin, a core component of the contractile apparatus in vascular smooth muscle cells and myofibroblasts. Its transcription is tightly controlled by serum response factor (SRF) and its coactivators myocardin and MRTF-A, which integrate signals from TGF-?? and RhoA pathways. TGF-??1 binding to its receptors triggers SMAD2/3 phosphorylation and nuclear translocation with SMAD4, cooperating with SRF/myocardin to drive ACTA2 expression. Concurrently, RhoA-ROCK-LIMK signaling modulates actin polymerization and actomyosin contractility. ACTA2 interacts with tropomyosin, myosin II, caldesmon, calponin, filamin A, ??-actinin, and plastin to form functional stress fibers, while downstream effectors such as transgelin, smooth muscle myosin heavy chain, and focal adhesion kinase propagate signals governing adhesion, migration, and matrix remodeling.
HEK293T cells exhibit negligible endogenous ACTA2 expression under standard conditions, rendering this knockout an exceptionally clean platform for functional studies. Upon TGF-?? stimulation, wild-type cells can upregulate ACTA2, whereas the knockout model allows unambiguous assessment of ACTA2??s contribution to myofibroblast-like differentiation, cytoskeletal reorganization, and contractile force generation. This system enables precise dissection of TGF-??/SMAD and RhoA/ROCK signaling crosstalk in regulating the smooth muscle actin cytoskeleton without confounding endogenous activity.
Researchers can employ this polyclonal knockout model in collagen gel contraction assays, TGF-?? dose-response analyses with phospho-SMAD2/3 readouts, immunocytochemistry for actin filaments, actin polymerization assays, and RT-qPCR or Western blotting for markers such as calponin and transgelin. Applications extend to epithelial-mesenchymal transition studies, migration/invasion assays, and anti-fibrotic drug screening. For additional information, contact Ascent Research.
